Chris Lee

Chris Lee’s practice focuses on formation, structuring, and operation of private investment funds. His experience covers a broad array of private fund strategies, including buyout, growth equity, venture, special situations, healthcare, climate, social impact and real estate funds, as well as “hybrid” funds, and various geographies, including pan-Asia, North Asia, Southeast Asia, China, and Korea. His work also includes advising sponsors and investors on secondary transactions, liquidity solutions, and other hybrid private equity transactions. He also represents institutional investors in connection with their investments in private investment funds.

Chris joined the firm in 2007, became counsel in 2017, and became partner in 2021. From 2007 to 2008 and 2016 to 2018, he was resident in the New York office, and from 2012 to 2015, he was resident in the Beijing office. Chris rejoined the Hong Kong office in 2018, and was also previously resident in Hong Kong from 2008 to 2012.

Chris has published widely on private equity, private debt, and regulatory developments affecting asset managers. His publications include GP-led Secondaries Come to Asia, Asia Pacific Private Debt: An Industry Poised for Growth, Negotiating GP Stakes Deals in Times of Economic Uncertainty, and The SEC’s Proposed “Preferential Treatment Rule”: When Equal Treatment Has an Unequal Effect.

Harvard Law School

J.D., cum laude

2006

Stanford University

B.A., honors with distinction

2001